Thermo Fisher Reports 22 Percent Revenue Growth for Q2, Raises Guidance for 2018

Jul 25, 2018

|

This article has been updated with additional comments from Thermo Fisher Scientific's earnings call.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 22 percent increase in second-quarter revenues that was partly driven by acquisitions and increased its revenue and earnings guidance for the year for the second time in a row.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Thermo Fisher Reports 22 Percent Revenue Growth for Q2, Raises Guidance for 2018

To read the full story....

Breaking News

Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production

Applied DNA Sciences to Provide Coronavirus Test to Stony Brook University Hospital

SphingoTec, BHR Pharmaceuticals Ink Dx Distribution Deal for UK, Ireland

Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

FDA Grants Emergency Use Authorization for Genetrack Biolabs SARS-CoV-2 Molecular Assay

US to Distribute 150 Million Abbott SARS-CoV-2 Antigen Tests at No Cost

What's Popular?

US to Distribute 150 Million Abbott SARS-CoV-2 Antigen Tests at No Cost

Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test

LabCorp Providing Lab Services for Infirmary Health

Sponsorships